Literature DB >> 4404957

The complement-binding and absorptive capacity of human white blood cells treated with neuraminidase.

E G Reisner, D B Amos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4404957     DOI： 10.1097/00007890-197210000-00008

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  7 in total

1.  [The effext of papain, neuraminidase and AET on the behavior of lymphocytes in cytotoxicity tests].

Authors:  F W Bube; H Heumann; D Seegers; E Siebel
Journal:  Blut       Date:  1975-07

2.  Mitogenic action of neuraminidase.

Authors:  G Semenzato; P Sarasin; G Amadori; G Gasparotto
Journal:  Experientia       Date:  1977-11-15

3.  Control mechanisms in infectious mononucleosis.

Authors:  A M Denman; B K Pelton
Journal:  Clin Exp Immunol       Date:  1974-09       Impact factor: 4.330

4.  Lymphocytes express Ia antigens of foreign haplotype following treatment with neuraminidase.

Authors:  C R Parish; T J Higgins; I F McKenzie
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

5.  Neuraminidase and tumor immunotherapy.

Authors:  H H Sedlacek; F R Seiler; H G Schwick
Journal:  Klin Wochenschr       Date:  1977-03-01

6.  Hemagglutination of neuraminidase-treated human erythrocytes by Leishmania enriettii infected guinea-pig sera.

Authors:  A C Ghose
Journal:  Experientia       Date:  1976-08-15

7.  Sheep red cell binding to human lymphocytes treated with neuraminidase; enhancement of T cell binding and identification of a subpopulation of B cells.

Authors:  Z Bentwich; S D Douglas; E Skutelsky; H G Kunkel
Journal:  J Exp Med       Date:  1973-06-01       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.